France’s top health body said recipients of a first dose of AstraZeneca’s traditional COVID-19 vaccine who are under 55 should get a second shot with a new-style messenger-RNA (mRNA) vaccine, confirming an earlier Reuters exclusive.
For more coronavirus news, visit our dedicated page.
The Haute Autorite de la Sante (HAS) regulator also said on Friday there should be an interval of 12 weeks between the two shots, in such cases.
The HAS added that it recommended a study to assess the immune responses given by these mixed vaccine prescriptions.
Two mRNA vaccines, one from Pfizer and BioNTech and another from Moderna, have been approved for use in France.
Confidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffered extremely unusual blood clots.
Australia doubles Pfizer COVID-19 vaccine order as AstraZeneca fears upend rolloutAustralia has doubled its order of the Pfizer Inc COVID-19 vaccine, Prime Minister Scott Morrison said on Friday, as the country raced to overhaul its ... Coronavirus
Philippines suspends use of AstraZeneca vaccine for people under 60Philippine health authorities suspended on Thursday the use of Astrazeneca’s COVID-19 vaccine for people below 60 years of age to investigate reports ... Coronavirus
Indonesia says arrival of 30 mln AstraZeneca vaccine doses delayed to 2022Indonesia’s health minister said on Thursday that the country would receive 20 million doses of the AstraZeneca COVID-19 vaccine via a bilateral deal ... Coronavirus